We found relatively low infiltration of CD8+ T cells in tumor parenchyma of stage IA NSCLC, but several markers, including age < 50, driver mutations in RAS‐MAPK pathway, and TMB‐H, appeared to be associated with relatively higher CD8+ T cell filtration. This evidence concerns the gene CD8A and neoplasm.